Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

The treatment effect in survival analysis is commonly quantified as the hazard ratio, and tested statistically using the standard log-rank test. Modern anticancer immunotherapies are successful in a proportion of patients who remain alive even after a long-term follow-up. This new phenomenon induces...

Full description

Bibliographic Details

Published in:	JNCI : Journal of the National Cancer Institute Vol. 111; no. 11; p. 1186
Main Authors:	Péron, Julien, Lambert, Alexandre, Munier, Stephane, Ozenne, Brice, Giai, Joris, Roy, Pascal, Dalle, Stéphane, Machingura, Abigirl, Maucort-Boulch, Delphine, Buyse, Marc
Format:	Journal Article
Language:	English
Published:	United States 01.11.2019
ISSN:	1460-2105, 1460-2105
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!